Cargando…

Fulminant Myocarditis 24 Days after Coronavirus Disease Messenger Ribonucleic Acid Vaccination

A 60-year-old Japanese woman was hospitalized for cardiogenic shock 24 days after receiving the second dose of the coronavirus disease 2019 BNT162b2 vaccine. Impella CP left ventricular assist device implantation and venoarterial peripheral extracorporeal membranous oxygenation were immediately init...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawano, Hiroaki, Motokawa, Tetsufumi, Kurohama, Hirokazu, Okano, Shinji, Akashi, Ryohei, Yonekura, Tsuyoshi, Ikeda, Satoshi, Izumikawa, Koichi, Maemura, Koji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424077/ https://www.ncbi.nlm.nih.gov/pubmed/35650138 http://dx.doi.org/10.2169/internalmedicine.9800-22

Ejemplares similares

Fulminant Myocarditis and Acute Appendicitis after COVID-19 Vaccination
por: Kawano, Hiroaki, et al.
Publicado: (2022)

The Relationship between Circulating Polyunsaturated Fatty Acid Levels and Exercise Responses of Patients with Non-ischemic Heart Failure
por: Izumida, Seiya, et al.
Publicado: (2019)

Comparison of Effectiveness and Safety Among 3 Direct Oral Anticoagulants in Patients With Venous Thromboembolism　― A Single-Center Retrospective Study ―
por: Ueno, Yuki, et al.
Publicado: (2022)

Effects of Vonoprazan on the Antiplatelet Function of Prasugrel Assessed by the VerifyNow P2Y(12) Assay in Patients With Coronary Artery Disease
por: Koga, Seiji, et al.
Publicado: (2020)

Vasospastic Angina: An Immune-related Adverse Event
por: Kumamoto, Taku, et al.
Publicado: (2021)

Comparison of Dasatinib- and Imatinib-Related Cardiotoxic Adverse Events in Japanese Patients With Chronic Myeloid Leukemia and Gastrointestinal Stromal Tumor
por: Motokawa, Tetsufumi, et al.
Publicado: (2021)

Life-threatening Vasospastic Angina Induced by Carteolol Eye Drops
por: Eto, Ryo, et al.
Publicado: (2022)

Effectiveness of Messenger Ribonucleic Acid Vaccine in Lung Transplant Recipients
por: Vender, R.J., et al.
Publicado: (2022)

Delayed Acute Perimyocarditis and Bilateral Facial Nerve Palsy in a Patient with COVID-19
por: Matsumura, Kazuki, et al.
Publicado: (2022)

Inherited Retinal Disease Therapies Targeting Precursor Messenger Ribonucleic Acid
por: Huang, Di, et al.
Publicado: (2017)

Early characteristics of fulminant myocarditis vs non-fulminant myocarditis: A meta-analysis
por: Wang, Zicheng, et al.
Publicado: (2019)

Multidisciplinary diagnostic approach for fulminant myocarditis related to coronavirus disease 2019 messenger RNA vaccines: a case report
por: Fujii, Masayoshi, et al.
Publicado: (2023)

Fulminant myocarditis in the time of coronavirus
por: Cuomo, Vittoria, et al.
Publicado: (2020)

Fulminant myocarditis and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

COVID-Induced Fulminant Myocarditis
por: Rodriguez Guerra, Miguel A, et al.
Publicado: (2022)

Long-term follow-up of cardiac magnetic resonance imaging in myocarditis following messenger ribonucleic acid COVID-19 vaccination: a case report
por: Kittichokechai, Pakaparn, et al.
Publicado: (2023)

Cap-dependent translation without base-by-base scanning of an messenger ribonucleic acid
por: Paek, Ki Young, et al.
Publicado: (2012)

Myopericarditis After the Pfizer Messenger Ribonucleic Acid Coronavirus Disease Vaccine in Adolescents
por: Schauer, Jenna, et al.
Publicado: (2021)

Fulminant myocarditis with myositis of ocular and respiratory muscles
por: Hiraiwa, Hiroaki, et al.
Publicado: (2020)

Calciphylaxis Diagnosed on Skin Biopsy in a Patient With Left Posterior Tibial Artery Stenosis
por: Kuwasaki, Shigeki, et al.
Publicado: (2019)

Transient Myocarditis Associated with Fulminant Colitis
por: Williamson, J. M. L., et al.
Publicado: (2011)

Fulminant Guillain-Barré Syndrome with Myocarditis
por: Mishra, Ajay, et al.
Publicado: (2014)

Fulminant myocarditis: Characteristics, treatment, and outcomes
por: Veronese, Giacomo, et al.
Publicado: (2018)

Consideration on pathogen of viral fulminant myocarditis
por: Wei, Xin, et al.
Publicado: (2020)

Fulminant myocarditis and COVID-19. Response
por: Irabien-Ortiz, Ángela, et al.
Publicado: (2020)

Fulminant myocarditis due to COVID-19
por: Irabien-Ortiz, Ángela, et al.
Publicado: (2020)

Fulminant Eosinophilic Myocarditis and VT Storm
por: Hoppens, Kyle R., et al.
Publicado: (2021)

Tozinameran: Fulminant myocarditis: case report
Publicado: (2022)

Anakinra in pediatric acute fulminant myocarditis
por: Maunier, Louise, et al.
Publicado: (2022)

Characteristics of Electrocardiogram Findings in Fulminant Myocarditis
por: Dai, Mei-Yan, et al.
Publicado: (2023)

Comprehensive Assessment of BARD1 Messenger Ribonucleic Acid Splicing With Implications for Variant Classification
por: Walker, Logan C., et al.
Publicado: (2019)

Messenger ribonucleic acid vaccine-associated immune thrombocytopenia: A rare complication of vaccine
por: Islamoglu, Mehmet Sami, et al.
Publicado: (2022)

Messenger ribonucleic acid vaccines against infectious diseases: current concepts and future prospects
por: Edwards, Darin K, et al.
Publicado: (2022)

Impact of mechanical circulatory support and immunomodulation therapy on outcome of patients with fulminant myocarditis: Chinese registry of fulminant myocarditis
por: Zhou, Ning, et al.
Publicado: (2021)

Case Report: Acute Fulminant Myocarditis and Cardiogenic Shock After Messenger RNA Coronavirus Disease 2019 Vaccination Requiring Extracorporeal Cardiopulmonary Resuscitation
por: Lim, Yongwhan, et al.
Publicado: (2021)

SYNTHESIS OF MESSENGER-LIKE RIBONUCLEIC ACID AND PROTEIN DURING MEIOSIS IN ISOLATED CELLS OF TRILLIUM ERECTUM
por: Hotta, Yasuo, et al.
Publicado: (1963)

Stress induced by messenger ribonucleic acid (RNA) vaccination may reveal acute adrenal insufficiency
por: Mariette, C., et al.
Publicado: (2021)

A Case of Autoimmune Hemolytic Anemia Following COVID-19 Messenger Ribonucleic Acid Vaccination
por: Brito, Sérgio, et al.
Publicado: (2021)

Messenger ribonucleic acid vaccines for severe acute respiratory syndrome coronavirus-2 – a review
por: Akamine, Christine M., et al.
Publicado: (2022)

Recent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review
por: Yihunie, Wubetu, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_81stntvfvq0eamb3h8bqmjp19o